PROSTASE PROTEIN VACCINE COMPRISING DERIVATISED THIOL RESIDUES AND METHODS FOR PRODUCING SAID ANTIGEN - Patent 1297118

(19)

(11)

EP 1 297 118 A1

(12)

(43)	Date of publication:
	02.04.2003 Bulletin 2003/14

(21)	Application number: 01949429.3

(22)	Date of filing: 21.06.2001

(51)	International Patent Classification (IPC)⁷: C12N 9/64, C07K 1/06, C07K 1/00, C07K 19/00, A61K 39/00, A61P 35/00 // C07K14:11

(86)	International application number:
	PCT/EP0107/081

(87)	International publication number:
	WO 0200/0867 (03.01.2002 Gazette 2002/01)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

27.06.2000 GB 0015722

(71)	Applicant: SMITHKLINE BEECHAM BIOLOGICALS S.A.
	1330 Rixensart (BE)

(72)	Inventors:
	CABEZON SILVA, Teresa, Elisa, Virginia B-1330Rixen sart (BE) PERMANNE, Philippe, Jean, Gervais, Ghislain B-1330 Rixensart (BE)

(74)	Representative: Dalton, Marcus Jonathan William
	GlaxoSmithKlineCorporate Intellectual Property (CN9.25.1)980 Great West Road BrentfordMiddlesex TW8 9GS BrentfordMiddlesex TW8 9GS (GB)

(54)	PROSTASE PROTEIN VACCINE COMPRISING DERIVATISED THIOL RESIDUES AND METHODS FOR PRODUCING SAID ANTIGEN